ImExHS Limited (ASX:IME)
0.3400
-0.0100 (-2.94%)
May 20, 2025, 3:31 PM AEST
ImExHS Revenue
In the year 2024, ImExHS had annual revenue of 26.54M AUD with 33.44% growth. ImExHS had revenue of 12.66M in the half year ending December 31, 2024, with 65.06% growth.
Revenue
26.54M
Revenue Growth
+33.44%
P/S Ratio
0.64
Revenue / Employee
66.34K
Employees
400
Market Cap
17.11M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.54M | 6.65M | 33.44% |
Dec 31, 2023 | 19.89M | 2.64M | 15.32% |
Dec 31, 2022 | 17.24M | 3.82M | 28.45% |
Dec 31, 2021 | 13.43M | 2.44M | 22.25% |
Dec 31, 2020 | 10.98M | 3.25M | 41.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Regis Healthcare | 1.10B |